Biotech Co.* |
Pharma Co. |
Product |
Terms/Details (Date) |
| |||
Bioenvision Inc. (OTC BB: BIOV) |
Penn Pharmaceutical Services Ltd. (UK) |
Clofarabine |
Penn Pharmaceutical will label, package, store and distribute clofarabine in Europe (5/15) |
|
|||
BioTime Inc. (AMEX:BTX) |
CJ Corp. (South Korea) |
Hextend and PentaLyte blood plasma volume expanders |
Exclusive licensing agreement for CJ to manufacture and sell the expanders in South Korea for human therapeutic uses; CJ will be responsible for obtaining regu- latory approvals and will bear all related costs and expenses (4/14) |
|
|
||
Celgene Corp. (CELG) |
GlaxoSmithKline plc (UK) |
Alkeran |
Celgene will buy Alkeran tablets and Alkeran for injection from GSK and then distribute the product under Celgene's label; financial details were not disclosed (4/14) |
|
|||
Eyetech Pharmaceuticals Inc.* |
Pfizer Inc. |
Xalatan |
Eyetech will participate in U.S. sales of Xalatan, a glaucoma medication (4/22) |
|
|||
Labopharm Inc. (Canada; TSE:DDS) |
Gruppo Angelini (Italy) and Esteve SA (Spain) |
A once-daily version of the analgesic tramadol |
Gruppo Angelini will market the product in Italy, and Esteve will market it in Spain and Portugal (4/22) |
|
|||
TolerRx Inc.* |
Laureate Pharma LP |
Monoclonal antibodies |
Manufacturing and services agreement regarding monoclonal antibodies from Toler-Rx under which it will provide purification and aseptic filling services to support TolerRx's clinical trials (3/26) |
|
|||
United Therapeutics Corp. (UTHR) |
Caremark Inc. |
Remodulin |
Caremark will distribute Remodulin in the U.S. for the treatment of pulmonary arterial hypertension (5/20) |
|
|||
| |||
Notes: | |||
# The information in the chart does not cover agricultural agreements or those between biotech companies. | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, stock symbols listed are on the Nasdaq market. | |||
AMEX = American Stock Exchange; OTC BB = Over-the-Counter Bulletin Board; TSE = Toronto Stock Exchange |